This review of the oral health status of dementia patients included 36 observational studies and highlights the high levels of plaque and many soft tissue related oral health problems suffered by this group of patients.
[read the full story...]
28 observational studies were included in this review of the oral health status of people with dementia. The findings suggest that compared with people without dementia those with dementia have poorer oral health.
[read the full story...]
The EQUATOR Publication School #EQPubSchool group summarise a systematic review and meta-analysis on the efficacy of antidepressants for depression in Alzheimer’s Disease, which finds no statistical difference between antidepressants and placebo.
[read the full story...]
This review of oral health in older people with dementia included 37 mainly observational studies of limited quality. The findings suggest that oral health was generally poorer in those with dementia.
[read the full story...]
Caroline Struthers scrutinises a systematic review on the longitudinal course of behavioural and psychological symptoms of dementia.
[read the full story...]
Clarissa Giebel reports on a systematic review and meta-analysis of factors predicting care placement of dementia sufferers into long-term care facilities.
[read the full story...]
Rosalyn Nelson summarises a recently updated Cochrane systematic review of statins for dementia prevention, which finds no evidence to support their use.
[read the full story...]
Akshay Nair explores the results of a systematic review of cognitive tests for dementia and mild cognitive impairment, which focuses on the MMSE, Mini-Cog, ACE-R and MoCA instruments. Along the way he explains how diagnostic tests work and how sensitivity and specificity are useful measures to get your head around.
[read the full story...]
Clarissa Giebel summarises a recent systematic review that investigates the effectiveness of various psychotherapies (CBT, interpersonal therapy, counselling) for depression and anxiety in people with dementia or mild cognitive impairment.
[read the full story...]
Rosalyn Nelson presents the latest Cochrane systematic review of Rivastigmine for Alzheimer’s disease, which brings together the results of 7 industry sponsored or funded trials, and concludes that Rivastigmine may be of benefit to people with Alzheimer’s disease.
[read the full story...]
